MedTrace Logo

Prospective Study for Neuromelanin Image Analysis

NCT05513794 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2025-07-28

No results posted yet for this study

Summary

In order to develop an image analysis system that automatically detects and quantifies neuromelanin, this study aims to construct a database of a wide sample by collecting brain MRI neuromelanin images prospectively.

Conditions

  • Parkinson Disease

Interventions

DEVICE

MRI Imaging

Neuromelanin sequence imaging

Sponsors & Collaborators

  • Heuron Inc.

    lead INDUSTRY

Principal Investigators

  • Phil Hyu Lee, M.D.pH.D · Severance Hospital, Yonsei University Health System

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-02
Primary Completion
2024-07-02
Completion
2024-07-02

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05513794 on ClinicalTrials.gov